by Chantal Allam, NCBiotech Writer April 16, 2021 .
GREENSBORO A brighter future for cats suffering from chronic kidney disease (CKD) could be on the horizon.
Greensboro-based Piedmont Animal Health, which develops, licenses and markets animal-health therapeutics, has teamed up with Wake Forest University’s Institute of Regenerative Medicine (WFIRM) to develop a novel therapy targeting the progressive and debilitating condition.
Often seen in older cats, there are currently no available treatments for CKD.
“With WFIRM in our backyard, and a combined interest in raising the standard of care, it was natural for the two of us to work together,” said Doug Hepler, Ph.D., Piedmont’s chief scientific officer.
Piedmont Animal Health and WFIRM look to create brighter future for cats with kidney disease einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
The Wake Forest Institute for Regenerative Medicine is investigating how cats with chronic kidney disease could someday help inform treatment for humans.
Cat Models Hold Potential To Treat Chronic Kidney Disease by Karishma Abhishek on March 14, 2021 at 7:08 AM The Wake Forest Institute for Regenerative Medicine (WFIRM), a study published online by Frontiers in Veterinary Science in the Veterinary Regenerative Medicine platform. Chronic kidney disease is a condition affecting 37 million people in the US (as per Centers for Disease Control), in which the kidneys are damaged and cannot filter blood as normal. This may progress to end-stage kidney failure, which is fatal without dialysis or a kidney transplant.
About 58 million cats in the United States are estimated to suffer from chronic kidney disease thereby affecting 30-50% of cats age 15 years or older, according to the
E-Mail
WINSTON-SALEM, NC - March 12, 2021 - The Wake Forest Institute for Regenerative Medicine is investigating how cats with chronic kidney disease could someday help inform treatment for humans.
In humans, treatment for chronic kidney disease a condition in which the kidneys are damaged and cannot filter blood as well as they should focuses on slowing the progression of the organ damage. The condition can progress to end-stage kidney failure, which is fatal without dialysis or a kidney transplant. An estimated 37 million people in the US suffer from chronic kidney disease, according to the Centers for Disease Control.
The American Veterinary Medical Association estimates there are about 58 million cats in the United States. Chronic kidney disease affects 30-50% of cats age 15 years or older. The fibrosis or scarring that occurs as a result of the disease is a common final pathway for kidney disease in both animals and people. For cats, end-stage kidney disease has no effe